These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
451 related items for PubMed ID: 11595210
1. Long-term neuroprotective effect of inhibiting poly(ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment. Ding Y, Zhou Y, Lai Q, Li J, Gordon V, Diaz FG. Brain Res; 2001 Oct 12; 915(2):210-7. PubMed ID: 11595210 [Abstract] [Full Text] [Related]
2. Neuroprotective effect of combination of poly (ADP-ribose) polymerase inhibitor and antioxidant in middle cerebral artery occlusion induced focal ischemia in rats. Gupta S, Kaul CL, Sharma SS. Neurol Res; 2004 Jan 12; 26(1):103-7. PubMed ID: 14977067 [Abstract] [Full Text] [Related]
3. Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia. Takahashi K, Pieper AA, Croul SE, Zhang J, Snyder SH, Greenberg JH. Brain Res; 1999 May 22; 829(1-2):46-54. PubMed ID: 10350529 [Abstract] [Full Text] [Related]
4. A comparative study of neuroprotective effect of single and combined blockade of AT1 receptor and PARP-1 in focal cerebral ischaemia in rat. Singh N, Sharma G, Singh N, Hanif K. Int J Stroke; 2014 Jul 22; 9(5):560-8. PubMed ID: 23013350 [Abstract] [Full Text] [Related]
5. Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase. Moroni F, Cozzi A, Chiarugi A, Formentini L, Camaioni E, Pellegrini-Giampietro DE, Chen Y, Liang S, Zaleska MM, Gonzales C, Wood A, Pellicciari R. Br J Pharmacol; 2012 Mar 22; 165(5):1487-500. PubMed ID: 21913897 [Abstract] [Full Text] [Related]
6. The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals. Koh SH, Park Y, Song CW, Kim JG, Kim K, Kim J, Kim MH, Lee SR, Kim DW, Yu HJ, Chang DI, Hwang SJ, Kim SH. Eur J Neurosci; 2004 Sep 22; 20(6):1461-72. PubMed ID: 15355313 [Abstract] [Full Text] [Related]
7. Chelating intracellularly accumulated zinc decreased ischemic brain injury through reducing neuronal apoptotic death. Zhao Y, Pan R, Li S, Luo Y, Yan F, Yin J, Qi Z, Yan Y, Ji X, Liu KJ. Stroke; 2014 Apr 22; 45(4):1139-47. PubMed ID: 24643405 [Abstract] [Full Text] [Related]
8. Enhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain. Tokime T, Nozaki K, Sugino T, Kikuchi H, Hashimoto N, Ueda K. J Cereb Blood Flow Metab; 1998 Sep 22; 18(9):991-7. PubMed ID: 9740102 [Abstract] [Full Text] [Related]
9. Inhibition of poly(ADP-ribose) polymerase: reduction of ischemic injury and attenuation of N-methyl-D-aspartate-induced neurotransmitter dysregulation. Lo EH, Bosque-Hamilton P, Meng W. Stroke; 1998 Apr 22; 29(4):830-6. PubMed ID: 9550519 [Abstract] [Full Text] [Related]
10. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. Endres M, Wang ZQ, Namura S, Waeber C, Moskowitz MA. J Cereb Blood Flow Metab; 1997 Nov 22; 17(11):1143-51. PubMed ID: 9390645 [Abstract] [Full Text] [Related]
11. Neuroprotective effects of poly (ADP-ribose) polymerase inhibitors in transient focal cerebral ischemia of rats. Sun AY, Cheng JS. Zhongguo Yao Li Xue Bao; 1998 Mar 22; 19(2):104-8. PubMed ID: 10374629 [Abstract] [Full Text] [Related]
12. 3-Aminobenzamide reduces brain infarction and neutrophil infiltration after transient focal cerebral ischemia in mice. Couturier JY, Ding-Zhou L, Croci N, Plotkine M, Margaill I. Exp Neurol; 2003 Dec 22; 184(2):973-80. PubMed ID: 14769390 [Abstract] [Full Text] [Related]
13. Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat. Kabra DG, Thiyagarajan M, Kaul CL, Sharma SS. Brain Res Bull; 2004 Feb 01; 62(5):425-33. PubMed ID: 15168908 [Abstract] [Full Text] [Related]
14. Impaired motor activity and motor learning function in rat with middle cerebral artery occlusion. Ding Y, Zhou Y, Lai Q, Li J, Park H, Diaz FG. Behav Brain Res; 2002 Apr 15; 132(1):29-36. PubMed ID: 11853855 [Abstract] [Full Text] [Related]
15. A newly synthesized poly(ADP-ribose) polymerase inhibitor, DR2313 [2-methyl-3,5,7,8-tetrahydrothiopyrano[4,3-d]-pyrimidine-4-one]: pharmacological profiles, neuroprotective effects, and therapeutic time window in cerebral ischemia in rats. Nakajima H, Kakui N, Ohkuma K, Ishikawa M, Hasegawa T. J Pharmacol Exp Ther; 2005 Feb 15; 312(2):472-81. PubMed ID: 15466246 [Abstract] [Full Text] [Related]
16. Neuroprotective effects of KCL-440, a new poly(ADP-ribose) polymerase inhibitor, in the rat middle cerebral artery occlusion model. Ikeda Y, Hokamura K, Kawai T, Ishiyama J, Ishikawa K, Anraku T, Uno T, Umemura K. Brain Res; 2005 Oct 26; 1060(1-2):73-80. PubMed ID: 16202986 [Abstract] [Full Text] [Related]
17. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia. Iwashita A, Tojo N, Matsuura S, Yamazaki S, Kamijo K, Ishida J, Yamamoto H, Hattori K, Matsuoka N, Mutoh S. J Pharmacol Exp Ther; 2004 Aug 26; 310(2):425-36. PubMed ID: 15075382 [Abstract] [Full Text] [Related]
18. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. Abdelkarim GE, Gertz K, Harms C, Katchanov J, Dirnagl U, Szabó C, Endres M. Int J Mol Med; 2001 Mar 26; 7(3):255-60. PubMed ID: 11179503 [Abstract] [Full Text] [Related]